As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.
13 Analysts have issued a Santen Pharmaceutical forecast:
13 Analysts have issued a Santen Pharmaceutical forecast:
Mar '25 |
+/-
%
|
||
Revenue | 300,004 300,004 |
1%
1%
|
|
Gross Profit | 171,027 171,027 |
4%
4%
|
|
EBITDA | 55,692 55,692 |
3%
3%
|
EBIT (Operating Income) EBIT | 46,880 46,880 |
6%
6%
|
Net Profit | 36,248 36,248 |
36%
36%
|
In millions JPY.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. The company is headquartered in Osaka, Osaka-Fu and currently employs 3,744 full-time employees. The firm has medical pharmaceutical business, OTC drugs business, medical devices business and other businesses. The firm engages in manufacture, sale and clinical development of medical pharmaceutical products, the development, manufacturing and sales of medical equipment, as well as the cleaning business. The firm operates in Japan, Europe, Asia, North America markets.
Head office | Japan |
Employees | 3,744 |
Website | www.santen.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.